YARDLEY, PA — Red Nucleus has announced its acquisition of COEUS, a leading consultancy specializing in market access strategies and communication services for the life sciences sector. The move aligns with Red Nucleus’ mission to deliver comprehensive solutions that ensure life-saving therapies reach patients efficiently and effectively.
Founded in 2009, COEUS has earned recognition for its expertise in market access, healthcare economics, and outcomes research (HEOR), as well as patient engagement and policy advocacy. The consultancy is particularly known for its work in supporting the commercialization of innovative therapies, including gene and cell treatments, rare disease drugs, and oncology products. The integration of COEUS’ capabilities will expand Red Nucleus’ service offerings, reinforcing its position as a leader in market access solutions for the global life sciences industry.
“Our core mission is to support the world’s leading life science companies bring critical new therapies to market, helping the patients who need them most,” said Mike Menta, CEO of Red Nucleus. “The extraordinary team at COEUS, and the capabilities they’ve built around market access, complement Red Nucleus’ industry-leading offerings in this space. Together, we have created the industry’s leading market access business. Our combined strength provides an invaluable benefit to our customers as we help ensure that life-saving drugs are made available to patients.”
COEUS brings a specialized approach to payor engagement, pricing strategies, and distribution models. Its team of experienced professionals and advisors offers end-to-end support in navigating the complexities of market access, from insights and strategy development to implementation. With these tools, clients are better positioned to optimize the launch and affordability of critical therapeutics.
“Red Nucleus is the ideal home for the COEUS team, our clients, and the patients we serve,” said Marc Hixson, CEO of COEUS, who will continue to lead the consultancy under Red Nucleus. “With a shared commitment to helping innovative life sciences companies turn molecules into life-saving therapies, we look forward to expanding our services and advancing this vital mission together.”
This acquisition highlights the growing demand for integrated market access solutions, as the life sciences sector continues to evolve with the development of cutting-edge therapies. By combining their expertise, Red Nucleus and COEUS are well-positioned to shape the future of healthcare delivery, ensuring that breakthrough treatments reach the patients who need them most.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.